GB Virus Type C: A Virus in Search of a Disease or a Role in HIV Therapy?

Clinical Infectious Diseases

Volumn 38, Issue 3, 2004, Pages 410-411

  Bollinger, Robert C ^a   Gupta, Amita ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CD4 ANTIGEN; ENVELOPE PROTEIN; GLYCOPROTEIN E2; PROTEIN ANTIBODY; PROTEIN E2 ANTIBODY; UNCLASSIFIED DRUG;

CELL FUNCTION; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; RNA EXTRACTION; SOUTH AFRICA; TH1 CELL; VERTICAL TRANSMISSION; VIREMIA; VIROLOGY; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

CD4 LYMPHOCYTE COUNT; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HIV INFECTIONS; HUMANS; MALE; PEST CONTROL, BIOLOGICAL; VIRAL LOAD;

EID: 1042300276     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/381102     Document Type: Note

References (13)

1. Stapleton JT. GB virus type C/hepatitis G virus. Seminars in Liver Disease 2003; 23: 137-48.
2. Lefrere JJ, Ferec C, Roudot-Thoraval F, et al. GBV-C/hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals. J Med Virol 1999; 59:32-7.
3. Zanetti AR, Tanzi E, Romano L, et al. Multicenter trial on mother-to-infant transmission of GBV-C virus. J Med Virol 1998; 54: 107-12.
4. Dickens T, Lemon SM. GB virus, hepatitis G virus or human orphan flavivirus? Hepatology 1997; 25:1285-6.
5. Heringlake S, Ockenga J, Tillmann HL, et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998; 177:1723-6.
6. Tillmann HL, Heiken H, Knapik-Botor A, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001; 345:715-24.
7. Nunnari G, Nigro L, Palermo F, et al. Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 2003; 139:26-30.
8. Chakraborty R, Rees G, Bourboulia D, et al. Related articles, viral coinfections among African children infected with human immunodeficiency virus type 1. Clin Infect Dis 2003; 36:922-4.
9. Sathar MA, York DF, Gouws E, Coutsoudis A, Coovadia HM. GB virus type C coinfection in HIV-infected African mothers and their infants, KwaZulu Natal, South Africa. Clin Infect Dis 2003; 38:405-9 (in this issue).
10. Agrati C, D'Offizi G, Narciso P, et al. Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic V delta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2001; 17:1357-63.
11. Poccia F, Gougeon ML, Agrati C, et al. Innate T-cell immunity in HIV infection: the role of Vγ9Vδ2 T lymphocytes. Curr Mol Med 2002; 2:769-81.
12. Gougeon ML, Malkovsky M, Casetti R, Agrati C, Poccia F. Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention? Vaccine 2002; 20:1938-41.
13. Lopez RD. Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases. Immunol Res 2002; 26: 207-21.